Macroautophagy/autophagy is a highly conserved process for degrading cytoplasmic contents, determines cell survival or death, and regulates the cellular homeostasis. Besides ATG
Introduction
Autophagy is a highly conserved "self-eating" process that controls the degradation of cytoplasmic contents within the lysosome and vacuole, and ensures the cellular homeostasis and the recycling of macromolecular constituents. [1] [2] [3] [4] [5] Although Christian de Duve coined the term "autophagy" at the Ciba Foundation symposium on lysosomes in 1963, the upsurge of research on autophagy emerged only after the discovery of autophagy-related (ATG) genes by using the yeast S. cerevisiae as a wonderful model organism for genetic screening. 3, 6 To date, 41 ATG genes have been identified, and nearly half of them are well conserved from yeast to human. 2, 4, 7 ATG genes and the autophagy process are extensively controlled by post-translational modifications (PTMs), transcriptional regulations, post-transcriptional regulations, and protein-protein interactions (PPIs), whereas hundreds of small chemicals can either induce or inhibit autophagy. 4, [7] [8] [9] Recent findings have clearly proved that autophagy play critical roles in the regulation of metabolism and membrane transport, 2, 4 and has diverse physiological and pathophysiological roles in starvation adaptation,
antiaging, immunity and various human diseases. 1, 10, 11 Although autophagy mainly serves as a cell survival mechanism during nutrient starvation, in certain states it may also induce programmed cell death (PCD) by excessively degrading the cellular contents. 12, 13 Besides autophagic cell death, apoptosis and necrosis can also trigger cell suicide, as the other two types of PCDs. [12] [13] [14] Autophagy, apoptosis, and necrosis have a complicated crosstalk to determine cell survival or suicide. 12, 13 The induction of apoptosis is inhibited by autophagy and apoptosis-associated caspase activation can diminish the autophagy process. 13 Under certain conditions, autophagy suppresses apoptosis to avoid cell death, whereas in other special cases, autophagy serves as an alternative cell death pathway or promotes apoptosis or necrosis to initiate cell death together. 12, 13 Previous studies suggest that autophagy, apoptosis and necrosis processes share common pathways in certain circumstances, and maintaining the relationship or balance among them is important for normal pathophysiological functions of organisms. 13, 15 Numerous experimental studies have identified a large number of genes and proteins involved in autophagy, apoptosis, and/or necrosis, while the collection, integration, and annotation of the data have emerged to be a great challenge. 2, 4, 5, 13 In 2003, Doctor et al. has first developed an apoptosis database, containing proteins with apoptotic domains, although these proteins may also be functional in nonapoptotic processes. 16 Later, Díez et al. mainly focuses on apoptosis, and constructs the DeathBase by collecting 213 PCD proteins from 5 model species. 17 More specifically, yApoptosis has been designated for the annotation of 51 apoptosis-associated proteins in S.
cerevisiae. 18 Due to the rapid progresses in quantitative proteomics, a great number of proteins genes directly or indirectly involved in autophagy, and construct a human autophagy database (HADb). 22 More recently, 739 autophagy-modulating proteins and 385 chemical inducers or inhibitors have carefully been curated, although a public database has not been released. 9 Besides the data collection and integration, computational analysis of autophagy and its crosstalk with cell death pathways has also become an attractive topic. systems. 24 The same authors also implement the miRDeathDB database for maintaining the miRNA-target relations in PCD network. 8, 25 In 2015, a highly useful autophagy resource termed the Autophagy Regulatory Network (ARN) was reported, containing 2,240 proteins and 386 miRNAs, including 38 ATG genes. 7 Multiple levels of regulations, such as PPIs, transcriptional regulations by transcription factors (TFs) and post-transcriptional regulations by miRNAs, are comprehensively considered and integrated. 7 However, the PTM regulations are not included, and the PTM-mediated crosstalk of autophagy with cell death pathways still remains to be dissected.
Recently, the importance of PTM regulations for ATG proteins has been well documented. 4 Here we further analyzed proteins and PTMs involved in autophagy and cell death pathways using 
Results

The collection and integration of experimentally identified proteins in the regulation of autophagy and cell death pathways
The flowchart of the study was shown in Fig. 1A . First, we searched PubMed to find experimentally identified AT, AP and/or NE proteins, and annotated each collected protein with a "+"
or "-" to distinguish the positive or negative regulation in autophagy or PCDs (Fig. 1A) . For example, it was demonstrated that the loss of ATG3 results in the deficiency of autophagosome formation in mice. 26 Thus, mouse ATG3 positively regulates autophagy, and has been annotated as AT+. Also, the inhibition of human SKP2, an important component of the SCF-SKP2 E3 ligase complex, can arrest the cell cycle progression and activate autophagy in myeloma cells. 27 In this regard, human SKP2 is negatively associated with autophagic activation, and was annotated as AT-. In addition, mouse ATG5 is essential for autophagic clearance of apoptotic cells during embryonic development, while autophagy is abolished in atg5 -/-embryoid bodies. 28 However, the phosphorylation of mouse ATG5 at Thr75 by MAPK14 inhibits starvation-induced autophagy. 29 Thus, mouse ATG5 was annotated as both AT+ and AT- (Fig. 1A) .
In this study, in total we obtained 4,237 experimentally characterized proteins in eukaryotes, Table S1 ). For each process, the proteins annotated only with "+" (only +) or "-" (only -), and with both "+" and "-" (+/-) were counted and shown, separately (Fig. 1B) . Also, we observed that there were 1,909 proteins from H. sapiens implicated in autophagy and cell death pathways, while only 189 autophagy and PCD proteins were reported in S. cerevisiae (Fig. 1B and Table S1 ). Thus, different species might contain considerably different numbers of proteins that participate in autophagy and PCDs. Furthermore, we found that a considerable proportion of proteins were involved in multiple processes (Fig. 1C) , and the overlap of known AT, AP and NE proteins for each organism was present (Fig. S1 ). 24 and ARN. 7 In total, there were 6,550 nonredundant proteins contained in the 8 databases, whereas 85.88% of the proteins (5,625) were integrated in only one database (Fig. S2A) . Only 2 proteins were collected in up to 6 databases, whereas no proteins were curated in ≥ 7 resources (Fig. S2A) . Also, we compared our data set with the 8 databases, and found that only 31.72% (1,344/4,237) of our proteins to be included in at least one public database ( Fig. 1D and Fig. S2B ). In this regard, our curated data set is much larger than previous data resources, mainly due to the rapid progress in the study of autophagy.
Development of THANATOS for eukaryotic proteins and PTMs involved in autophagy, apoptosis and necrosis
The orthologous information of known AT, AP and NE proteins will be potentially useful for discovering new regulators, since orthologs across different species might have conserved functions (Table S2) .
Combined with both known and computationally identified proteins, the distribution of the number of identified proteins for each organism is shown in Fig. 2 elegans, A. thaliana and S. cerevisiae (Table S4) . Most of the PTM sites were identified from mass spectrometry-based proteomic profiling, while whether and how many PTM sites directly linked to autophagy and PCDs still remain to be dissected. Finally, we developed the comprehensive THANATOS database for known and predicted proteins, while primary references for known proteins and other annotations from the UniProt database 30 were also present.
The online service of the THANATOS database was developed in an easy-to-use manner.
The database contained 4 search options, including "Simple search" (Fig. 3A) , "Advanced search"
( Fig. 3B) , "Batch search" (Fig. 3C) , and "BLAST search" (Fig. 3D ). For example, if a keyword "ulk1"
in "Gene/Protein Name" was directly submitted for a simple search (Fig. 3A) , all related proteins across eukaryotes, will be shown. Also, the option of "Advanced Search" allows a more accurate query that 2 terms combined with operators of "and", "or" and "exclude" can be specified in 2 different fields ( Fig. 3B) . For example, searching the database with "Homo sapiens" in "Species" and "ulk1" in "Gene/Protein Name" will return the information of human ULK1 in a tabular format with accession, evidence, species, and protein or gene names (Fig. 3B) . By clicking the accession "ANA-HSA-111744", the detailed annotations of human ULK1 can be shown. Moreover, users can submit a list of keywords for a batch search (Fig. 3C ). In addition, users can submit a protein sequence in FASTA format in "BLAST Search" to find identical or homologous proteins in THANATOS (Fig. 3D) . THANATOS can also be browsed by multiple options (Fig. S3 ). 
An evolutionary analysis of ATG genes
Previously, an evolutionary analysis was performed for 17 ATG genes across 17 photosynthetic eukaryotes, and demonstrated that the autophagy pathway is conserved in green algae and chromalveolates, but not in red algae. 31 With the orthologous information, here we performed a comprehensive analysis of the evolution of 41 ATG genes (Fig. 4) , and the known ATG genes in the 8 model organisms were also shown ( Table S5 ). In eukaryotes, only orthologs of the known ATG genes were adopted for further analyses. It should be noted that ATG39, ATG40 and ATG41 were only found in the yeast S. cerevisiae, and currently no orthologs were detected in other eukaryotes (Fig. 4) . Also, 5 ATG genes including ATG25, ATG28, ATG30, ATG35 and ATG37 are encoded in the yeast Komagataella pastoris (also called Pichia pastoris) but not in S. cerevisiae (Table S5) . Although ATG25 and ATG30 were only found in K. pastoris, the orthologs of ATG28, ATG35 and ATG37 were detected in a number of other eukaryotes (Fig. 4) .
In S. cerevisiae, both Atg11 and Atg17 interact with Atg1 and Atg9 as scaffold/adaptor proteins, and mainly participate in the cytoplasm-to-vacuole targeting (Cvt) and macroautophagy pathways, respectively. 32, 33 It has been demonstrated that Drosophila Atg17/RB1CC1 and mammalian RB1CC1/FIP200 are functional equivalents of yeast ATG17. 32, 34 However, Lin et al.
have found that the C termini of nematode ATG-11/EPG-7, mammalian RB1CC1 and yeast Atg11
are considerably similar and contain the Atg11 motif (Pfam motif PF10377). 35 Indeed, nematode ATG-11 was computationally identified as an ortholog of human RB1CC1 in this study. Thus, although there was no significant similarity in protein sequences between yeast Atg11 and Atg17, we classified ATG11 and ATG17 into a single group due to the sequence similarity in more complex eukaryotes and the functional similarity in autophagy (Fig. 4 , Table S5 ). In protein sequences, yeast Atg3 and Atg10 possess the same consensus domain as Autophagy_act_C (Pfam domain PF03987), and both were annotated as ubiquitin-like conjugating enzymes in UniProt. Also, yeast
Atg18 is highly similar with Atg21 in sequences, and both proteins contain WD repeats. Although Atg20 and Snx4/Atg24 only exhibit considerable sequence similarity in S. cerevisiae, the 2 proteins were annotated with a conserved PX domain (Pfam domain PF00787). Due to the sequence and functional similarity, we classified ATG3 and ATG10, ATG18 and ATG21, as well as ATG20 and SNX4/ATG24 into 3 groups, respectively (Fig. 4 , Table S5 ). In addition, although yeast Atg38 and mammalian NRBF2 are not significantly similar in amino acid sequences, experimental studies demonstrate that NRBF2 is a functional ortholog of Atg38. 36 We manually added the information for further analyses (Table S5) .
One ATG gene can be a singleton in one species but have multiple paralogs in other
organisms. For example, yeast ATG1 has 5 human orthologs including ULK1, ULK2, ULK3, ULK4
and STK36. 37 Besides ATG1, we observed that ATG2, ATG4, ATG6, ATG8, ATG9 and ATG16 are singleton genes in S. cerevisiae but have multiple copies in animals or plants (Fig. 4) . In particular, although ATG12 has only one copy in most of species, it has a few duplications in Brassicales, which underwent large-scale duplication events that occurred at 100 to 200 million years ago. 38 In total, there were 15 ATG genes including ATG15, ATG19, ATG25, ATG27 to ATG34, ATG36, and ATG39
to ATG41 to be fungus specific, whereas their orthologs in animals or plants were not detected (Fig.   4) . Furthermore, 18 ATG genes were highly conserved (ATG1 to ATG10, ATG11 and ATG17, ATG13, ATG16, ATG18 and ATG21, ATG20 and SNX4/ATG24), and their orthologs can be readily found in over 85% (140) of 164 eukaryotes (Fig. 4) . Most of these ATG genes are involved in autophagosome formation, and our analysis supported the idea that the machinery of the autophagy pathway is highly conserved in eukaryotes. 39 In to ATG41, respectively ( Fig. 4 and Table S5 ).
Autophagy proteins and regulators are preferentially associated with human diseases
To investigate whether and how AT proteins are preferentially involved in human diseases, we first obtained 2,247 known human drug targets from the DrugBank database, 40 and 559 well-curated cancer genes from the Cancer Gene Census in the Catalogue Of Somatic Mutations In Cancer (COSMIC). 41 Then we mapped human AT proteins to the 2 datasets, and found that 261 and 95 AT proteins were annotated as known drug targets and cancer genes, with the enrichment ratios of 2.85-and 4.17-fold, respectively (Fig. 5A) . Obviously, our results proposed that known drug targets and cancer genes were enriched in autophagy against the human proteome (Fig. 5A) . To further understand the functional distribution of known human AT proteins beyond the regulation of autophagy, we performed an enrichment analysis based on pathway annotations from the database of Kyoto Encyclopedia of Genes and Genomes (KEGG), 42 using the hypergeometric distribution (P value < 1E-12). From the results, we observed that AT proteins were significantly overrepresented in several signaling pathways, such as the TNF signaling pathway (KEGG ID: hsa04668), the NOD-like receptor signaling pathway (hsa04621), the TLR signaling pathway (hsa04620), and the FOXO signaling pathway (hsa04068) (Fig. 5B and Table S6 ). In particular, a number of disease pathways are enriched in human AT proteins ( Fig. 5B and (Table S6) .
Currently, KEGG annotations are still limited and the numbers of proteins involved in biological pathways are far from fully annotated. For example, KEGG only annotated 53 human proteins as "regulation of autophagy" (hsa04140) (Fig. 5B and Table S6 ). To avoid any bias, we performed a systematic analysis of cancer mutations of AT genes, by using the cancer genomic data. First, we downloaded all nonsynonymous somatic mutations together with mutated gene lists of pancreatic adenocarcinoma and prostate cancer from the International Cancer Genome Consortium (ICGC) database, 45 respectively. We mapped 928 known human AT proteins to mutated genes in the 2 cancers, and found that there were 854 and 54 AT genes with a mutation frequency of ≥ 5% in pancreatic adenocarcinoma and prostate cancer, respectively (Table S7) . For simplicity, 54
AT genes with a mutation frequency of ≥ 12% were visualized for pancreatic adenocarcinoma (Fig.   5C ), and all mutated AT genes with a frequency of ≥ 5% were present for prostate cancer (Fig. 5D) .
The known and highly potential PPIs among these AT genes were also shown, if available ( Fig. 5C   and D) . From the results, we observed that up to 30 ATG genes were frequently mutated in pancreatic adenocarcinoma (Table S7) . For example, MAP1LC3A/LC3A, GABARAPL1 and MAP1LC3B/LC3B, 3 mammalian ortholog members of the yeast ATG8 family, were highly mutated with the frequency values of 13.58%, 12.83% and 12.50%, respectively ( Fig. 5C and Table S7 ). In contrast, there were only 2 ATG genes, ATG5 and WIPI1, the latter being an ortholog of yeast ATG18, that are frequently mutated in prostate cancer ( Fig. 5D and Table S7 ).
To probe how many mutated AT proteins can be potentially therapeutic drug targets for the 2 cancers, we obtained human drug-target relations from DrugBank, 40 and then mapped all mutated AT genes to the data set. From the results, we found that 79 and 4 proteins might be targeted pharmacologically in pancreatic adenocarcinoma and prostate cancer, with at least one applicable drug approved by Food and Drug Administration (FDA), respectively (Table S7) . For convenience, the relations between available drugs and 50 AT genes with a mutation frequency of ≥ 8% were shown for pancreatic adenocarcinoma (Fig. 5E) , while we also presented the drug-target relations for all mutated AT genes in prostate cancer (Fig. 5F) . Although no ATG proteins were observed to be targeted pharmacologically in the current stage, we found that a number of autophagy regulators can be potentially targeted in the 2 cancers (Fig. 5E, F, and pancreatic adenocarcinoma, while 2 taxanes, docetaxel and paclitaxel, can stabilize microtubule dynamics and target MAPT (Fig. 5E) . 46 Both agents are effective anticancer drugs, and nanoparticle albumin-bound paclitaxel (nab-paclitaxel) plus gemcitabine was approved by the FDA in 2013 for the treatment of advanced pancreatic adenocarcinoma. 47 Interestingly, autophagy promotes chemoresistance of cancer cells to docetaxel and paclitaxel, whereas targeting autophagy enhances the anti-tumor effects of the 2 drugs. 48, 49 Also, we observed that ESR1 (estrogen receptor 1) is highly mutated in both cancers, and up to 31 drugs were approved to target this protein ( Fig. 5E and F) .
Although none of the drugs have been approved for the prevention of advanced pancreatic adenocarcinoma, a number of them were widely used for the therapy of prostate cancer, such as diethylstilbestrol (DES) and estramustine. 50 In addition, a tyrosine kinase gene, ALK, is frequently mutated in both cancers ( Fig. 5E and F) . At least 3 small-molecule drugs, including crizotinib, ceritinib and alectinib, have been approved for the therapy of non-small-cell lung cancer. 51 In particular, crizotinib activates autophagy in multiple lung cancer cell lines, and the inhibition of autophagy enhances its efficacy for the induction of cell death. 52 Although the effectiveness of most drugs for the 2 cancers remains to be characterized, our multiple analyses demonstrated that AT proteins are highly associated with human diseases, indicating autophagy can be a promising target in disease therapy. (Table S1 ) to EKPD database, and identified 92 kinases and 11 phosphatases to be involved in autophagy ( Fig. 6A and Table S8 ). Using the hypergeometric distribution (P value < 0.05), 54 statistical analyses demonstrated that kinases were more significantly over-represented in AT than phosphatases ( Fig. 6A and For a better understanding of phosphoregulations in the machinery of the autophagy pathway, we used a previously developed tool of in vivo group-based prediction system (iGPS) 56 for the reconstruction of the KSPNs among ATGs and their regulatory kinases for H. sapiens (Fig. 7A) , M. musculus ( Fig. 7B) and S. cerevisiae (Fig. 7C) , respectively. In both human and mouse networks, BECN1/Vps30/Atg6 has the most kinase-substrate relations, and can be phosphorylated by 92 and 71 kinases in H. sapiens (Fig. 7A) and M. musculus (Fig. 7B) , respectively. However, no kinase was found to phosphorylate its ortholog in yeast, Vps30/Atg6/BECN1, whereas Atg1 was mostly phosphorylated by 21 kinases in S. cerevisiae (Fig. 7C) . For regulatory protein kinases, the serine/threonine kinase AKT1 phosphorylates the most ATG proteins, with 9 and 7 substrates in H.
Phosphorylation is essential in regulating the autophagy pathway
sapiens (Fig. 7A) and M. musculus (Fig. 7B) , respectively. Interestingly, a member of AKT family, Ypk2, also phosphorylates the most ATG proteins with 21 substrates in S. cerevisiae (Fig. 7C) .
Although human ULK1 (one of the human orthologs of yeast Atg1) was predicted to be regulated by 40 kinases, it was the mostly hyperphosphorylated protein among all ATGs with up to 61 phosphorylation sites. The phosphorylation sites with at least one predicted kinase were shown for human ULK1, and nearly half of the sites were modified by the kinase activity of MTOR (Fig. 7D) .
Most of these ssKSRs have not been reported previously, and our predictions can be useful for further experimental consideration. Taken together, our results suggested that phosphorylation plays an important role in the regulation of autophagy. (Fig. 8B) . Using the human proteome as the background, the statistical analyses demonstrated that all types of PTMs were statistically enriched in human AT proteins ( Fig. 8C and Table S9 ). Our analyses are consistent with a previous summarization, which emphasized the importance of phosphorylation, ubiquitination and acetylation in autophagy.
Various PTMs are highly associated with autophagy
regulators including 10 ubiquitin-activating enzymes (E1s), 43 ubiquitin-conjugating enzymes (E2s), 700 ubiquitin-protein ligases (E3s) and 120 deubiquitination enzymes (DUBs) from a previously constructed database of UUCD. 57 We mapped curated human AT proteins to the data set, and observed that E1s, E3s and DUBs but not E2s were significantly enriched against the human proteome ( Fig. 8D and Table S8 ). Taken together, our analyses suggested that various PTMs are important in regulating autophagy pathways, while the results can be useful for further experimental manipulation.
Discussion
Recently, autophagy has emerged to be an intriguing biological process, and has attracted much attention for extensive research. [1] [2] [3] [4] [5] [6] It is demonstrated that autophagy plays essential roles in a broad spectrum of physiological, developmental and pathophysiological processes, and has been associated with human diseases such as neurodegenerative diseases, inflammatory diseases, and cancers. 1, 10, 11 Besides 41 ATG proteins, a large number of regulators have also been discovered to regulate autophagy in multilevels. 2, 4, [7] [8] [9] In particular, numerous PTMs, such as phosphorylation, ubiquitination, acetylation and sumoylation, are important in the regulation of autophagy. 4 Thus, the collection, curation and integration of experimentally identified regulators and PTMs will be helpful for understanding the molecular mechanisms of autophagy at a systems-level, and provide highly useful information for further experimental consideration. Although a number of data sets or resources for autophagy and cell death pathways have been developed, 7-9, 16-25 the corresponding known PTM information still remains to be integrated. 4 In this study, we manually collected and curated 4,237 known AT, AP and NE proteins from the literature, and this number was much greater than previous efforts ( Fig. 1D and Fig. S2 Although not all annotations were consistent between human proteins and their ortholgs in other organisms, the high consistency of the experimental evidences suggested that the orthologous transfer of annotations across species is much reliable.
By mapping protein kinases to human AT proteins, we observed that phosphorylation play a similar role in autophagy and mitosis and cell cycle pathways (Fig. 6) . For example, Dr. Leland H.
Hartwell firstly established the yeast S. cerevisiae as an excellent model for genetic screening, and identified cell-division cycle (Cdc) mutants that regulate mitosis and cell cycle. 62 Similarly, a number of ATG genes were also screened and discovered in yeast. 6 Second, both types of processes are highly conserved across eukaryotes with conserved genes. 2, 3, 5, 6, 62 Third, besides phosphorylation, 4 both autophagy, and mitosis and cell cycle were dynamically but precisely regulated in multiple levels, such as transcriptional and post-translational regulations. 4, [7] [8] [9] Fourth, both autophagy and mitosis are multistage process. For example, a typical autophagic process contains 3 steps, including phagophore formation, autophagosome generation, and its fusion with lysosomes for degrading the contents. 4, 5 Analogously, mitosis also contains several steps, including prophase, metaphase, anaphase and telophase, to orchestrate the proper segregation of sister chromatids. 54 Fifth, various protein complexes will be formed during either autophagy or mitosis at distinct cellular compartment. For example, the ATG1/ULK complex, ATG9 and its cycling system, and the PtdIns3K complex are part of the machinery of autophagy, 2, 4, 39 whereas hundreds of proteins form different complexes at midbody, centrosome and kinetochore during mitosis. 54, 63 Sixth, both autophagy and mitosis and the cell cycle are highly associated with human diseases. 1, 10, 11 Finally, 2 processes can crosstalk with each other mediated by specific regulators. 27, 64, 65 For example, although MAPK1 and MAPK3 regulate the autophagic process, 65 they also play a role in determining mitotic spindle angle during early lung development. 64 The numerous analogies of autophagy, and mitosis and cell cycle emphasized the importance of scientific researches in autophagy.
Taken together, we manually collected 4,237 known proteins and further computationally characterized 191,543 potentials AT, AP and NE proteins in 164 eukaryotes. For our future plans, a number of efforts should be taken. First, more species will be considered and included in the database. Second, proteins may have different regulatory functions in different types of cells and tissues. 58, 59 Thus, the tissue-specific information will be carefully curated from the primary literature and integrated into the database. Also, the PTM sites were mainly identified from high-throughput experiments, and the exact functions of most of the sites were unknown. Besides the curation of autophagy-associated PTM events from the literature, we will perform experiments to discover new PTM regulators or substrates involved in autophagy. Moreover, since over 380 autophagy inducers or inhibitors together with their targeting proteins have been reported, the information is highly useful for further research, and will be integrated into our database. In addition, the multilayer data beyond proteins and PTMs, such as mRNA expression data, ncRNAs and cancer mutations, will be collected and maintain THANATOS. The database will be continuously maintained and updated,
and we believe such a data resource can provide helpful information for both experimental and computational analyses.
Materials and Methods
Data collection and curation
From the scientific literature, we manually collected experimentally identified proteins that participate in autophagy and cell death pathways. Multiple keywords, such as "autophagy", "autophagic", "apoptosis", "apoptotic", "necrosis" and "necroptosis", were used to query the PubMed search engine. We also considered the information from several well annotated data resources, such as ARN, 7 DeathBase, 17 and the autophagy census. 9 Each protein entry in these databases was rechecked by searching PubMed to ensure the data quality. The obtained abstracts or full papers were carefully read, and proteins with unambiguously experimental evidence were preserved. As previously described, 2, 4, 7 41 ATG genes were denoted as "autophagy proteins", whereas other proteins that also contribute in regulating autophagy were denoted as "autophagy regulators". For each protein entry, the "+" or "-" was used to distinguish the positive or negative regulation for autophagy, apoptosis or necrosis, as previously described. 9 All protein sequences were retrieved from the Ensembl database.
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Orthologous detection
To identify potential orthologs of known AT, AP and NE proteins, we downloaded the Because multiple variant nucleotide sequences or peptides can be originated from a single gene, we used Ensembl Gene ID as the unique accession to eliminate the redundancy. For multiple alternatively splicing isoforms of a single gene, only the longest one was reserved. As previously described, 63 the strategy of reciprocal best hits (RBHs) was chosen, and the blastall program in the BLAST package was utilized.
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The data set of PPIs The pupylation sites were not used because pupylation only occurs in prokaryotes. Also, because crotonylation sites were mainly identified in histones, this PTM was not considered. All PTM sites were mapped to all identified proteins of the 7 species, to pinpoint the exact modification sites. 
The statistical enrichment analysis
To analyze the preferentially distributed pathways of known human AT proteins, we Then the enrichment ratio (E-ratio) of the KEGG pathway t was calculated, and the P value was calculated with the hypergeometric distribution as below:
, (E-ratio ≥ 1), or
, (E-ratio < 1)
In this work, we only considered the over-represented KEGG pathways with E-ratio ≥ 1. Based on the sequence and functional similarity, we also classified ATG3 and ATG10, ATG18 and ATG21, as well as ATG20 and SNX4/ATG24 into 3 groups, respectively. Clearly, there were 18 highly conserved ATG genes including ATG1 to ATG10, ATG11 and ATG17, ATG13, ATG16, ATG18 and ATG21, ATG20 and SNX4/ATG24. Their orthologs were detected in more than 85%
(140) of 164 eukaryotes, and most of these ATG genes are involved in autophagosome formation. Table S6 . The most significant KEGG pathways of known human AT proteins. The hypergeometric distribution was adopted, and the threshold was selected with a P value < 1E-12. Table S7 . All human AT genes with a mutation frequency of ≥ 5% in prostate cancer and pancreatic adenocarcinoma, respectively. The ATG genes are marked in gray background. 
